8-K 1 f8k091515_oxysuresys.htm CURRENT REPORT




Washington, D.C. 20549





Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934


Date of report (Date of earliest event reported): September 15, 2015




OxySure Systems, Inc.

(Exact name of registrant as specified in its charter)




Delaware   000-54137   71-0960725
(State or other jurisdiction
of incorporation or organization)
  (Commission file number)   (IRS Employer
Identification No.)




10880 John W. Elliott Drive, Suite 600
Frisco, TX 75033
(Address of Principal Executive Offices)


(972) 294-6450
(Registrant’s Telephone Number, Including Area Code)




Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


☐   Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425).

☐   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).

☐   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).

☐   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).







ITEM 5.07 Submission of Matters to a Vote of Security Holders


At the Company’s Special Meeting of Stockholders held on September 15, 2015, the Company’s stockholders voted on, and approved, two proposals, the final voting results of which are provided below.


Proposal No. 1 ‒ Reverse Stock Split. The Company’s stockholders approved the proposal to authorize an amendment to the Company’s Articles of Incorporation to effect a reverse stock split of our common stock, par value $0.0004, at a specific ratio, within a range of 1-for-2 and 1-for-100 shares, to be determined by our Board of Directors in its sole discretion and effected, if at all, within one year from the date of the Special Meeting.


For   Against   Abstain
17,897,811   284,113   17,320


Proposal No. 2 ‒ Increase in Authorized Shares. The Company’s stockholders approved the proposal to authorize an amendment to the Company’s Articles of Incorporation to increase the authorized shares of the Company’s common stock, par value $0.0004, from 100,000,000 shares to 500,000,000 shares.


For   Against   Abstain
17,589,101   407,643   202,500


- 2 -





Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date:  September 17, 2015 OxySure Systems, Inc.
  By: /s/ Julian T. Ross
  Name: Julian T. Ross
  Title: Chairman, Chief Executive Officer, President, and Chief Financial Officer



- 3 -